LOADING
Comparing Salesforce Inc (CRM) and Thermo Fisher Scientific (TMO) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | CRM | TMO |
|---|---|---|
| Price | $174.81 | $440.04 |
| Change Today | +4.31% | -1.82% |
| Market Cap | $135.7B | $166.6B |
| P/E Ratio | 21.3 | 24.6 |
| Forward P/E | 13.8 | 18.7 |
| PEG Ratio | 0.99 | 1.53 |
| EPS | $7.79 | $18.20 |
| Revenue Growth (YoY) | 12.1% | 6.2% |
| Profit Margin | 18.0% | 15.1% |
| Return on Equity | 12.4% | 13.5% |
| Dividend Yield | 0.97% | 0.39% |
| Beta | 1.14 | 0.88 |
| 52-Week High | $290.01 | $643.35 |
| 52-Week Low | $163.52 | $384.44 |
| Volume | 196K | 136K |
Thermo Fisher Scientific is the larger company by market capitalization. Salesforce Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Salesforce Inc offers a higher dividend yield for income investors. Salesforce Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.